Sage Therapeutics has said it will cut its headcount ... whose responsibilities will be taken over by chief medical officer Laura Gault. Head of medical affairs Mark Pollack is also stepping ...

Sage Therapeutics is rated a Strong Buy due to its undervaluation, trading below cash holdings, and potential in its drug pipeline, especially Zuranolone. Biogen's $7.22 per share buyout offer ...

Sage Therapeutics has faced significant setbacks, losing 90% of its value, but still holds potential with Zurzuvae, the only FDA-approved treatment for postpartum depression. Despite recent ...

"We are delighted to welcome Laura to Sail’s Board of Directors. She has both breadth and depth of experience in advancing nucleic acid therapeutics and a distinguished record in drug discovery ...

Find Your Next Book Romance Novels N.Y.C. Literary Guide Nonfiction Spring Preview Fiction Spring Preview Advertisement Supported by nonfiction In “Unshrunk,” Laura Delano chronicles her ...

The Chicago Bears hired Laura Anderson to be their senior vice president of administration and chief financial officer, the team announced Monday. Anderson comes to the Bears after seven years at ...

Laura, 78, sat down with her twin daughters, Jenna Bush Hager and Barbara Pierce Bush, in a previously taped interview that aired on Today on Tuesday, March 25. During the segment, Laura recalled ...

There’s no doubt Laura Bush is a proud mom and grandma. The former first lady, 78, sat down for a heartwarming interview with her daughters, Jenna Bush Hager and twin sister Barbara Pierce Bush ...

President Donald Trump arranged for far-right activist Laura Loomer to join him in the Oval Office this week for an extraordinary meeting that preceded a shake-up of his national security ...

Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. Feel unsure about the ...